Appeals court overturns a Monsanto win on Roundup cancer issue
A federal appeals court has rejected a bid by Monsanto owner Bayer AG to head off claims brought by cancer victims alleging that Monsanto failed to warn them of the risks of Roundup.
A federal appeals court has rejected a bid by Monsanto owner Bayer AG to head off claims brought by cancer victims alleging that Monsanto failed to warn them of the risks of Roundup.
In fresh evidence of the pervasive nature of pesticides, more than 80 percent of urine samples drawn from children and adults participating in a US health study contained a weedkilling chemical linked to cancer and other health problems.
Earlier this month, a court decision about a chemical called glyphosate garnered headlines in newspapers across the country. And rightly so: glyphosate is the active ingredient in Monsanto’s Roundup weedkiller.
The US Supreme Court on Monday dealt another blow to Bayer AG’s effort to defend itself against ongoing litigation over allegations that Roundup herbicide causes cancer, denying the company’s request for a review of a California trial loss.
A Kansas City, Mo., jury on Thursday dismissed claims by a man who blamed his cancer on exposure to Monsanto’s Roundup herbicide, agreeing with the company that the weed killer was not the source of the man’s disease.
Former Monsanto chief Hugh Grant spent several hours on the witness stand on Tuesday – testifying for the first time in front of a jury at a Roundup trial – telling the court repeatedly that global regulators had found no evidence that the company’s herbicides cause cancer.
Two weeks after a top Justice Department official advised the U.S. Supreme Court there was “no sound reason” for the high court to review a loss by Monsanto owner Bayer AG in nationwide Roundup cancer litigation, a coalition of large agricultural groups is demanding that President Joe Biden withdraw the opinion.
The U.S. Solicitor General on Tuesday dealt a blow to Monsanto owner Bayer AG, advising the U.S. Supreme Court that it should deny the company’s request for a review of a key Roundup cancer trial loss.
Nearly four years after the first-ever trial over allegations that exposure to Roundup herbicide causes cancer a new trial was underway on Tuesday, pitting a 34-year-old man suffering from non-Hodgkin lymphoma (NHL) against Monsanto owner Bayer AG.
As we collectively pass what many consider to be two-year anniversary of COVID emergence, the field of clinical research has never been more visible in our day-to-day lives. Published studies on viral mechanisms, promising treatments, and vaccine development, among other COVID-related topics, have dominated media reports since early 2020.
Unfortunately, the laser-like focus on the story of COVID has left other research areas in the shadows, fighting for time, attention, and funding.